Abiomed (NASDAQ:ABMD) reported quarterly earnings of $1.12 per share which beat the analyst consensus estimate of $1.09 by 2.75 percent. This is a 15.46 percent increase over earnings of $0.97 per share from the same period last year. The company reported quarterly sales of $221.6 million which missed the analyst consensus estimate of $226.85 million by 2.31 percent. This is a 10.49 percent increase over sales of $200.563 million the same period last year.
- GAAP net income was $69.2 million, or $1.51 per diluted share, which includes a $17.8 million, or $0.39 per share, unrealized gain from our investment in Shockwave. This compares to GAAP net income of $44.9 million or $0.97 per diluted share for the prior fiscal year.